BIOMAT Database Logo BIOMAT Database Logo

Evolution of preleukaemia (myelodysplastic syndrome) into acute non-lymphocytic leukaemia. 1987

K Krishnarathnam, and P P Bapsy, and P K Muthukumaraswamy, and V Vijayasarathy, and V Vedamurthy, and U Majhi, and T G Sagar, and V Maithreyan, and V Shanta

UI MeSH Term Description Entries
D008297 Male Males
D011289 Preleukemia Conditions in which the abnormalities in the peripheral blood or bone marrow represent the early manifestations of acute leukemia, but in which the changes are not of sufficient magnitude or specificity to permit a diagnosis of acute leukemia by the usual clinical criteria. Preleukemias
D004915 Leukemia, Erythroblastic, Acute A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood. Di Guglielmo's Disease,Erythremic Myelosis,Erythroblastic Leukemia, Acute,Erythroleukemia,Leukemia, Myeloid, Acute, M6,Myeloid Leukemia, Acute, M6,Di Guglielmo Disease,Acute Erythroblastic Leukemia,Acute Erythroblastic Leukemias,Di Guglielmos Disease,Disease, Di Guglielmo,Disease, Di Guglielmo's,Erythremic Myeloses,Erythroblastic Leukemias, Acute,Erythroleukemias,Leukemia, Acute Erythroblastic,Leukemias, Acute Erythroblastic,Myeloses, Erythremic,Myelosis, Erythremic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy

Related Publications

K Krishnarathnam, and P P Bapsy, and P K Muthukumaraswamy, and V Vijayasarathy, and V Vedamurthy, and U Majhi, and T G Sagar, and V Maithreyan, and V Shanta
Myelodysplastic syndrome transformed into Acute Lymphoblastic Leukaemia (FAB:L3).
August 2006, Clinical and laboratory haematology,
K Krishnarathnam, and P P Bapsy, and P K Muthukumaraswamy, and V Vijayasarathy, and V Vedamurthy, and U Majhi, and T G Sagar, and V Maithreyan, and V Shanta
Klinefelter syndrome: predisposition to acute non-lymphocytic leukaemia?
May 1980, Lancet (London, England),
K Krishnarathnam, and P P Bapsy, and P K Muthukumaraswamy, and V Vijayasarathy, and V Vedamurthy, and U Majhi, and T G Sagar, and V Maithreyan, and V Shanta
Klinefelter syndrome: predisposition to acute non-lymphocytic leukaemia?
April 1980, Lancet (London, England),
K Krishnarathnam, and P P Bapsy, and P K Muthukumaraswamy, and V Vijayasarathy, and V Vedamurthy, and U Majhi, and T G Sagar, and V Maithreyan, and V Shanta
Acute non-lymphocytic leukaemia.
February 1980, Clinics in haematology,
K Krishnarathnam, and P P Bapsy, and P K Muthukumaraswamy, and V Vijayasarathy, and V Vedamurthy, and U Majhi, and T G Sagar, and V Maithreyan, and V Shanta
Megakaryocyte polyploidization in acute leukaemia and preleukaemia.
October 1974, British journal of haematology,
K Krishnarathnam, and P P Bapsy, and P K Muthukumaraswamy, and V Vijayasarathy, and V Vedamurthy, and U Majhi, and T G Sagar, and V Maithreyan, and V Shanta
Transformation into acute basophilic leukaemia in a patient with myelodysplastic syndrome.
March 1995, British journal of haematology,
K Krishnarathnam, and P P Bapsy, and P K Muthukumaraswamy, and V Vijayasarathy, and V Vedamurthy, and U Majhi, and T G Sagar, and V Maithreyan, and V Shanta
Management of acute non-lymphocytic leukaemia.
May 1974, Irish journal of medical science,
K Krishnarathnam, and P P Bapsy, and P K Muthukumaraswamy, and V Vijayasarathy, and V Vedamurthy, and U Majhi, and T G Sagar, and V Maithreyan, and V Shanta
Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemia.
December 1983, British journal of haematology,
K Krishnarathnam, and P P Bapsy, and P K Muthukumaraswamy, and V Vijayasarathy, and V Vedamurthy, and U Majhi, and T G Sagar, and V Maithreyan, and V Shanta
Bone marrow response to chemotherapy in acute lymphocytic leukaemia and acute non-lymphocytic leukaemia.
August 1985, Scandinavian journal of haematology,
K Krishnarathnam, and P P Bapsy, and P K Muthukumaraswamy, and V Vijayasarathy, and V Vedamurthy, and U Majhi, and T G Sagar, and V Maithreyan, and V Shanta
The 5q- chromosome in preleukaemia and acute leukaemia.
August 1981, Scandinavian journal of haematology,
Copied contents to your clipboard!